Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors

被引:0
|
作者
Jakubowski, M
Levy, D
Goor-Aryeh, I
Collins, B
Bajwa, Z
Burstein, R
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Anaesthesia, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Crit Care, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:844 / 845
页数:2
相关论文
共 50 条
  • [1] Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors
    Jakubowski, M
    Levy, D
    Goor-Aryeh, I
    Collins, B
    Bajwa, Z
    Burstein, R
    [J]. HEADACHE, 2005, 45 (07): : 850 - 861
  • [2] Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors
    Jakubowski, M
    Levy, D
    Goor-Aryeh, I
    Collins, B
    Bajwa, Z
    Burstein, R
    [J]. HEADACHE, 2005, 45 (06): : 766 - 766
  • [3] Inhibition of COX1/COX2 activity by substituted chalcones and flavones
    Mateeva, NN
    Mills, CJ
    Redda, KK
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U148 - U148
  • [4] CONTRIBUTION OF COX1 AND COX2 TO PROSTACYCLIN RELEASE BY HEALTHY MOUSE TISSUES
    Kirkby, N. S.
    Harrington, L. S.
    Lundberg, M. H.
    Hoefer, T.
    Warner, T. D.
    Mitchell, J. A.
    [J]. INFLAMMATION RESEARCH, 2011, 60 : 116 - 117
  • [5] Towards a universal barcode of oomycetes - a comparison of the cox1 and cox2 loci
    Choi, Young-Joon
    Beakes, Gordon
    Glockling, Sally
    Kruse, Julia
    Nam, Bora
    Nigrelli, Lisa
    Ploch, Sebastian
    Shin, Hyeon-Dong
    Shivas, Roger G.
    Telle, Sabine
    Voglmayr, Hermann
    Thines, Marco
    [J]. MOLECULAR ECOLOGY RESOURCES, 2015, 15 (06) : 1275 - 1288
  • [6] Changes in COX1 and COX2 regulation in normal and neoplastic human prostate
    Jackson, BA
    Rodriguez, E
    Shaikh, A
    Young, L
    Perryman, T
    Shor, E
    Tovar, D
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 334A - 335A
  • [7] COX1 and COX2 polymorphisms and gastric cancer risk in a Polish population
    Hou, Lifang
    Grillo, Paolo
    Zhu, Zhong-Zheng
    Lissowska, Jola
    Yeager, Meredith
    Zatonski, Witold
    Zhu, Guanshan
    Baccarelli, Andrea
    Chanock, Stephen J.
    Fraumeni, Joseph F., Jr.
    Chow, Wong-Ho
    [J]. ANTICANCER RESEARCH, 2007, 27 (6C) : 4243 - 4247
  • [8] Differential Effect of COX1 and COX2 Inhibitors on Renal Outcomes following Ischemic Acute Kidney Injury
    Bischoff, Ariane
    Bucher, Michael
    Gekle, Michael
    Sauvant, Christoph
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2014, 40 (01) : 1 - 11
  • [9] Control of cardiovascular and renal function through COX1 and COX2 derived prostanoids
    Breyer, Matthew D.
    Hao, Chuanming
    Schneider, Andre
    Qi, Zhonghua
    Guan, Youfei
    Zhang, Yahua
    Breyer, Richard M.
    [J]. ACTA PHARMACOLOGICA SINICA, 2006, 27 : 45 - 45
  • [10] COX1 and COX2 both play roles in interleukin-1-induced behaviour
    Dunn, AJ
    Swiergiel, AH
    [J]. JOURNAL OF NEUROCHEMISTRY, 2001, 78 : 51 - 51